Genetic alterations, RNA expression profiling and DNA methylation of HMGB1 in malignancies

The high mobility group box 1 (HMGB1) is a potential biomarker and therapeutic target in various human diseases. However, a systematic, comprehensive pan‐cancer analysis of HMGB1 in human cancers remains to be reported. This study analysed the genetic alteration, RNA expression profiling and DNA met...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shoukai, Qian, Lingmei, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344825/
https://www.ncbi.nlm.nih.gov/pubmed/35765707
http://dx.doi.org/10.1111/jcmm.17454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344825/
https://www.ncbi.nlm.nih.gov/pubmed/35765707
http://dx.doi.org/10.1111/jcmm.17454

Ejemplares similares